Teva Pharmaceutical Finance Netherlands II BV

CIK 1628587 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Teva Pharmaceutical Finance Netherlands II BV.

Recent SEC filings

FiledFormAccession number
Sep 11, 2026424B50001193125-26-389382
Sep 9, 2026424B50001193125-26-386121
May 22, 2025424B50001193125-25-125044
May 19, 2025424B50001193125-25-122087
Feb 7, 2025S-3ASR0001193125-25-022747
Mar 3, 2023424B50001193125-23-058961
Feb 27, 2023424B50001193125-23-049644
Nov 4, 2021424B50001193125-21-320227
Oct 27, 2021S-3ASR0001193125-21-308706
Oct 27, 2021424B30001193125-21-308773
Aug 17, 2020424B30001193125-20-221916
Aug 17, 2020EFFECT9999999995-20-002171
Aug 5, 2020S-40001193125-20-210725
Apr 19, 2018424B30001193125-18-122692
Apr 2, 2018S-40001193125-18-105032
Mar 28, 2018S-3/A0001193125-18-099579
Feb 16, 2018S-3/A0001193125-18-048694
Jan 29, 2018S-30001193125-18-023821
Jul 13, 2016POSASR0001193125-16-646966
Feb 9, 2015F-3ASR0001193125-15-039213